MRI作为小鼠部分肝切除模型中肝脏再生药理学实验的主要终点
研究对47只行部分肝切除的雄性B6小鼠进行无门控、无对比剂增强的MRI肝脏体积测量,并与死后肝重及Ki67表达对照,验证MRI肝脏体积测量作为肝再生定量指标的可行性;结果显示MRI体积与肝重高度相关(R=0.98,P=1.5×10⁻¹⁴),并能可靠监测TCPOBOP治疗后的肝再生增强(R=0.96,P=2×10⁻⁶)。
要点
- MRI肝脏体积测量与死后肝重高度相关(R=0.98,P=1.5×10⁻¹⁴)。
- MRI可可靠监测TCPOBOP治疗后的肝再生增强(R=0.96,P=2×10⁻⁶)。
- 相比终末操作,绘制肝再生曲线所需肝切除小鼠数量减少6倍。
核心结论
- 已建立无需在多个时间点处死小鼠的MRI肝脏再生监测方法,并证明该影像方法可用于肝再生药理学研究。
研究设计与样本
- 研究论文;对47只雄性B6小鼠行部分肝切除术,其中6只接受TCPOBOP治疗、6只接受对应溶剂;MRI扫描14.5分钟,麻醉后自主呼吸,无门控、无对比剂;参考标准为死后总肝重和组织学Ki67表达。
关键影像表现/征象
- MRI-derived肝脏体积与死后肝重高度相关(R=0.98,P=1.5×10⁻¹⁴)。
- MRI可靠监测TCPOBOP治疗后小鼠肝再生增强,经比较肝细胞增殖(Ki67表达)和肝重分析确认(R=0.96,P=2×10⁻⁶)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: The study aimed to validate magnetic resonance imaging (MRI)-based liver volumetry as a quantitative measure of hepatic regeneration in mice subjected to partial hepatectomy, in view of routine in vivo pharmacologic studies characterizing compounds aiming to accelerate liver regeneration.
MATERIALS AND METHODS: Partial hepatectomy was performed in male B6 mice (n = 47). Images were acquired in 14.5 minutes from anesthetized and spontaneously respiring animals, without any gating and without administration of contrast material. Some of the mice (n = 6) were treated with 1, 4-bis [2-(3, 5-dichloropyridyloxy)] benzene (TCPOBOP), a synthetic agonist of mouse constitutive androstane receptor, or with the corresponding vehicle (n = 6). Postmortem analyses included total liver weight and histologic Ki67 expression.
RESULTS: A highly significant correlation (R = 0.98, P = 1.5 × 10-14) was obtained between the MRI-derived liver volumes and the postmortem liver weights in hepatectomized, untreated mice. MRI reliably monitored enhanced murine liver regrowth following treatment with TCPOBOP, as confirmed by comparative hepatocyte proliferation (Ki67 expression) and liver weight analysis (R = 0.96, P = 2 × 10-6).
CONCLUSIONS: MRI-based monitoring of liver regrowth in mice without the requirement of euthanizing animals at several time points has been established. In comparison to terminal procedures, the number of hepatectomized mice needed to derive a liver (re)growth curve was reduced by a factor of 6. The feasibility of using this imaging approach in pharmacologic studies in the context of liver regeneration has been demonstrated.
引用
- Orsini V, Zurbruegg S, Pikiolek M, et al. MRI as Primary End Point for Pharmacologic Experiments of Liver Regeneration in a Murine Model of Partial Hepatectomy. Acad Radiol. 2016. PMID: 27595407. doi:10.1016/j.acra.2016.07.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。